UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000048923
Receipt No. R000055745
Scientific Title Clinical study of lymph node metasitasis without neck dissection classification in oral cancer
Date of disclosure of the study information 2022/09/13
Last modified on 2022/09/13 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical study of lymph node metasitasis without neck dissection classification in oral cancer
Acronym Clinical study of lymph node metasitasis without neck dissection classification in oral cancer
Scientific Title Clinical study of lymph node metasitasis without neck dissection classification in oral cancer
Scientific Title:Acronym Clinical study of lymph node metasitasis without neck dissection classification in oral cancer
Region
Japan

Condition
Condition Oral cancer
Classification by specialty
Oral surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 The aim of the present study is to assess the treatment modality and prognosis on LLN and LRPN in patients diagnosed OSCC.
Basic objectives2 Others
Basic objectives -Others Future improvements in treatment outcomes will be discussed.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Treatment outcome and prognosis
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who underwent surgery-based treatment for oral squamous cell carcinoma between June 1, 2008 and December 31, 2021, and had metastasis in the outer cervical lymph nodes at the level of oral cancer.
Key exclusion criteria Cases in which medical information records are poorly documented and insufficient information is available
Target sample size 17

Research contact person
Name of lead principal investigator
1st name Tomofumi
Middle name
Last name Naruse
Organization Nagasaki University
Division name Department of Clinical Oral Oncology
Zip code 852-8588
Address 1-7-1 Sakamoto, Nagasaki 852-8588, Japan
TEL 0958197698
Email naruse12@nagasaki-u.ac.jp

Public contact
Name of contact person
1st name Tomofumi
Middle name
Last name Naruse
Organization Nagasaki University
Division name Department of Clinical Oral Oncology
Zip code 852-8588
Address 1-7-1 Sakamoto, Nagasaki 852-8588, Japan
TEL +81958197698
Homepage URL
Email naruse12@nagasaki-u.ac.jp

Sponsor
Institute Nagasaki University
Institute
Department

Funding Source
Organization Nagasaki University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Department of Clinical Oral Oncology, Graduate School of Biomedical Sciences, Nagasaki University
Address 1-7-1 Sakamoto, Nagasaki 852-8588, Japan
Tel 0958197698
Email naruse12@nagasaki-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2022 Year 09 Month 13 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2022 Year 09 Month 13 Day
Date of IRB
2022 Year 09 Month 13 Day
Anticipated trial start date
2022 Year 09 Month 13 Day
Last follow-up date
2022 Year 09 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information No.

Management information
Registered date
2022 Year 09 Month 13 Day
Last modified on
2022 Year 09 Month 13 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055745